Catalyst Wire Dossier Catalyst Wire Dossier

ABT-199

venetoclax · AbbVie
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ABT-199, covering 2021-12-16 to 2023-08-21. Get the full timeline:

Most recent: Clinical Trial Update: ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM) [Phase 2]

See pricing